- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Drug Pipelines
- July 2023
- 139 Pages
Global
From €10612EUR$10,995USD£9,103GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4778EUR$4,950USD£4,098GBP
- Report
- October 2023
- 83 Pages
United States
From €3378EUR$3,500USD£2,898GBP
- Report
- May 2018
- 204 Pages
Global
From €2267EUR$2,349USD£1,945GBP
- Report
- June 2018
- 155 Pages
Global
From €603EUR$625USD£517GBP
€1206EUR$1,250USD£1,035GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more